Mymetics Corp (MYMX)

[Staypositive1]

Mario is staying busy...

Positive Delegate Experiences at BOS BASEL 2018

7th August 2018

Comments from participants at BOS BASEL 2018 which took place on the 19th and 20th June at the Congress Centre Basel, Basel, Switzerland:

"Perfect event for networking and screening new CMOs/CROs, in a functional location with good atmosphere. Informative talks with many helpful examples of collaborative interactions."
Dr Mario Amacker, Head of Quality, Mymetics BV

“BOS Basel 2018 was a success as it provided the opportunity to introduce ProQR Therapeutics NV, gave the forum to network with existing CDMO’s and get in-touch with new CDMO’s and (re-)connect with CMC colleagues in the pharma industry.”
Maarten Van Geffen, Senior Director, Clinical Supplies & Logistics, ProQR Therapeutics

“The expansion to discovery has broadened the conference and have brought in a complementary focus.”
Dr Alexander Bausch, CEO, Strekin AG

“BOS 2018 in Basel, especially attending the biologics workstream, was a very valuable event for me, with excellent presentations on outsourcing biologics development and manufacture and great opportunities for networking and partnering.”
Ulrich Ruemenapp. Head of Launch Preparation and Coordination, Bayer

“The BOS Basel 2018 was a great event with lots of insights in outsourcing topics. It was a great opportunity to increase understanding and to do some networking. The sessions were evenly balanced between customers and vendors. QBDC will attend the next meeting once more.”
Karlheinz Landauer, Managing Director, Quality Biotech Development & Cells GMBH

"For anacura the BOS Basel 2018 event was an excellent opportunity to meet customers and to connect with new prospects. Both size and focus of the event were excellent for this purpose. The presentations and the partnering tool were most helpful to connect with CMC professionals and discuss new trends, developments and needs in the field of CMC analytics for DS and DP including small molecules, biologics and cell based medicinal therapies. I am looking forward to the 2019 event."
Eddy Ruijter, Business Development Manager, anacura

"I have found this event very dynamic, with meetings that allowed me to meet different customers and new prospects. My first participation in 2018 has been really useful and I did appreciate the conferences as relevant and well organised. In short, a very well coordinated event and a willingness to participate in the next edition!"
Aurélie MOREAU, Business Development Manager, ATLANCHIM PHARMA

"BOS BASEL 2018 is a great forum for UK & EU Pharma to meet up with each other and the Life Science suppliers serving this market."
Rick Connell, Pfizer Inc. 

Please see the BOS 2018 website for further details at: http://www.bio2bevents.com/forthcoming-events/bos2018